Status:
UNKNOWN
Clinical Study on Chinese Children's Asthma Action Plan
Lead Sponsor:
Beijing Children's Hospital
Collaborating Sponsors:
Tian Jing Children's Hospital
Capital Institute of Pediatrics, China
Conditions:
Asthma in Children
Eligibility:
All Genders
6-14 years
Phase:
NA
Brief Summary
This study is a multi-center randomized controlled trial of children with asthma. The objective of the study is to assess the efficacy of China Children Asthma Action Plan (CCAAP), which is the first ...
Detailed Description
Asthma is the most common chronic illness of childhood. Asthma action plans have been recommended internationally for more than 20 years by the Global Initiative for Asthma and have been shown to impr...
Eligibility Criteria
Inclusion
- did not receive control treatment or did not reach well-control;
- can perform spirometry pulmonary function tests;
- parents are skilled in using smartphones and APP apps (Android or IOS).
Exclusion
- reach the level of asthma control;
- can not use the smartphone APP software;
- can not cooperate the test of peak expiratory flow;
- did not treatment coexist respiratory disease effectively (such as sinusitis, obstructive sleep apnea-hypopnea syndrome, etc.);
- combined with other systemic diseases outside the respiratory system (such as leukemia, rheumatoid arthritis, etc.).
- receiving allergen-specific immunotherapy.
- undergoing trial for other medications or instruments.
Key Trial Info
Start Date :
March 22 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2019
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT03435822
Start Date
March 22 2018
End Date
June 30 2019
Last Update
March 20 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.